Putnam Investments LLC Y M Abs Therapeutics, Inc. Transaction History

Putnam Investments LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$29.16 - $51.96 $3.36 Million - $5.99 Million	-115,202 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$37.86 - $54.26 $104,834 - $150,245	2,769 Added 2.46%	115,202 $5.7 Million
Q3 2020 Nov 16, 2020	BUY	$35.13 - $43.62 $259,716 - $322,482	7,393 Added 7.04%	112,433 $4.32 Million
Q2 2020 Aug 14, 2020	BUY	$23.66 - $49.53 $400,327 - $838,047	16,920 Added 19.2%	105,040 $4.54 Million
Q1 2020 May 15, 2020	SELL	$14.39 - $35.8 $1.95 Million - $4.86 Million	-135,632 Reduced 60.62%	88,120 $2.3 Million
Q4 2019 Feb 14, 2020	BUY	$23.81 - $33.78 $2.7 Million - $3.83 Million	113,352 Added 102.67%	223,752 $6.99 Million
Q3 2019 Nov 14, 2019	BUY	$21.57 - $31.37 $2.38 Million - $3.46 Million	110,400 New	110,400 $2.88 Million

114

27M

5.6K

900

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $241M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.